These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23676999)

  • 41. Monitoring EGFR-mutant lung cancers by means of the blood.
    Pao W
    J Thorac Oncol; 2006 Mar; 1(3):199-200. PubMed ID: 17409855
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.
    Kim HR; Oh IJ; Shin MG; Park JS; Choi HJ; Ban HJ; Kim KS; Kim YC; Shin JH; Ryang DW; Suh SP
    J Korean Med Sci; 2011 May; 26(5):625-30. PubMed ID: 21532852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer.
    Kammer MN; Kussrow AK; Webster RL; Chen H; Hoeksema M; Christenson R; Massion PP; Bornhop DJ
    ACS Comb Sci; 2019 Jun; 21(6):465-472. PubMed ID: 31022347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.
    Clamon G; Zeitler W; An J; Hejleh TA
    Am J Clin Oncol; 2020 Sep; 43(9):670-675. PubMed ID: 32889839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between EGFR mutations and serum tumor markers in lung adenocarcinoma patients.
    Pan JB; Hou YH; Zhang GJ
    Asian Pac J Cancer Prev; 2013; 14(2):695-700. PubMed ID: 23621221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer.
    Sabater L; Bataller L; Suárez-Calvet M; Saiz A; Dalmau J; Graus F
    J Neuroimmunol; 2008 Sep; 201-202():163-5. PubMed ID: 18639938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
    Ge YL; Liu CH; Wang MH; Zhu XY; Zhang Q; Li ZZ; Li HL; Cui ZY; Zhang HF; Zhang X; Yu HL; Fu AS; Wang HY
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer.
    Liu L; Teng J; Zhang L; Cong P; Yao Y; Sun G; Liu Z; Yu T; Liu M
    Biomed Res Int; 2017; 2017():2013989. PubMed ID: 28607926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer.
    Lin MW; Su KY; Su TJ; Chang CC; Lin JW; Lee YH; Yu SL; Chen JS; Hsieh MS
    Lung Cancer; 2018 Nov; 125():282-290. PubMed ID: 30429033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
    Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis.
    Zhao WX; Luo JF
    Tumour Biol; 2013 Oct; 34(5):3245-8. PubMed ID: 23775010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of
    Bai H; Xia J; Zhao X; Gong Z; Zhang D; Xiong L
    J Clin Pathol; 2019 May; 72(5):379-385. PubMed ID: 30787028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
    El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
    Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis.
    Zhu Y; Wei Y; Zhang R; Dong X; Shen S; Zhao Y; Bai J; Albanes D; Caporaso NE; Landi MT; Zhu B; Chanock SJ; Gu F; Lam S; Tsao MS; Shepherd FA; Tardon A; Fernández-Somoano A; Fernandez-Tardon G; Chen C; Barnett MJ; Doherty J; Bojesen SE; Johansson M; Brennan P; McKay JD; Carreras-Torres R; Muley T; Risch A; Wichmann HE; Bickeboeller H; Rosenberger A; Rennert G; Saliba W; Arnold SM; Field JK; Davies MPA; Marcus MW; Wu X; Ye Y; Le Marchand L; Wilkens LR; Melander O; Manjer J; Brunnström H; Hung RJ; Liu G; Brhane Y; Kachuri L; Andrew AS; Duell EJ; Kiemeney LA; van der Heijden EH; Haugen A; Zienolddiny S; Skaug V; Grankvist K; Johansson M; Woll PJ; Cox A; Taylor F; Teare DM; Lazarus P; Schabath MB; Aldrich MC; Houlston RS; McLaughlin J; Stevens VL; Shen H; Hu Z; Dai J; Amos CI; Han Y; Zhu D; Goodman GE; Chen F; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):935-942. PubMed ID: 30700444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
    Jiang R; Dong X; Zhu W; Duan Q; Xue Y; Shen Y; Zhang G
    PLoS One; 2017; 12(9):e0184338. PubMed ID: 28877268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial.
    Bulbul A; Araujo-Mino E
    Future Oncol; 2019 Jan; 15(1):81-94. PubMed ID: 30175621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.